rs201435578
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 1P and 11B. PP2BP4_ModerateBP6BS1BS2
The NM_001367721.1(CASK):c.1411G>A(p.Asp471Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000208 in 1,201,332 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001367721.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CASK | NM_001367721.1 | c.1411G>A | p.Asp471Asn | missense_variant | 15/27 | ENST00000378163.7 | NP_001354650.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CASK | ENST00000378163.7 | c.1411G>A | p.Asp471Asn | missense_variant | 15/27 | 5 | NM_001367721.1 | ENSP00000367405 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000449 AC: 5AN: 111324Hom.: 0 Cov.: 22 AF XY: 0.0000298 AC XY: 1AN XY: 33550
GnomAD3 exomes AF: 0.0000819 AC: 15AN: 183182Hom.: 0 AF XY: 0.0000591 AC XY: 4AN XY: 67652
GnomAD4 exome AF: 0.0000183 AC: 20AN: 1090008Hom.: 0 Cov.: 28 AF XY: 0.0000169 AC XY: 6AN XY: 355636
GnomAD4 genome AF: 0.0000449 AC: 5AN: 111324Hom.: 0 Cov.: 22 AF XY: 0.0000298 AC XY: 1AN XY: 33550
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 31, 2017 | The p.D471N variant (also known as c.1411G>A), located in coding exon 15 of the CASK gene, results from a G to A substitution at nucleotide position 1411. The aspartic acid at codon 471 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 15, 2021 | - - |
Intellectual disability, CASK-related, X-linked Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 27, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at